[
  {
    "ts": "2025-09-15T22:21:00+00:00",
    "headline": "Quest Diagnostics to Speak at the Jefferies Healthcare Services Conference",
    "summary": "Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that Sam Samad, Executive Vice President and Chief Financial Officer, will speak on the company's strategy, performance and the latest market developments and trends during the Jefferies Healthcare Services Conference in Nashville on Monday, September 29, 2025, at 4:35 p.m. Eastern Time.",
    "url": "https://finance.yahoo.com/news/quest-diagnostics-speak-jefferies-healthcare-222100658.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "f0e1550d-f286-3f1b-92c3-b344b74bb775",
      "content": {
        "id": "f0e1550d-f286-3f1b-92c3-b344b74bb775",
        "contentType": "STORY",
        "title": "Quest Diagnostics to Speak at the Jefferies Healthcare Services Conference",
        "description": "",
        "summary": "Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that Sam Samad, Executive Vice President and Chief Financial Officer, will speak on the company's strategy, performance and the latest market developments and trends during the Jefferies Healthcare Services Conference in Nashville on Monday, September 29, 2025, at 4:35 p.m. Eastern Time.",
        "pubDate": "2025-09-15T22:21:00Z",
        "displayTime": "2025-09-15T22:21:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/596f9c53c019a633fa68d8b76e9b4722",
          "originalWidth": 400,
          "originalHeight": 190,
          "caption": "questhealth.com logo (PRNewsfoto/Quest Diagnostics)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/v6s3D2c6OzmZrj.0kIY12Q--~B/aD0xOTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/596f9c53c019a633fa68d8b76e9b4722.cf.webp",
              "width": 400,
              "height": 190,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AFrizODjj_bBgmzRgIgaqw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/596f9c53c019a633fa68d8b76e9b4722.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-speak-jefferies-healthcare-222100658.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/quest-diagnostics-speak-jefferies-healthcare-222100658.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-15T13:01:00+00:00",
    "headline": "US Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic",
    "summary": "The United States Drug Abuse Testing Market is projected to grow significantly, reaching US$ 3.71 billion by 2033, up from US$ 2 billion in 2024, reflecting a CAGR of 7.11% from 2025 to 2033. This growth is driven by increasing substance misuse, stringent workplace regulations, technological advancements, government support, and rising public awareness. The sector is essential in tackling drug-related challenges through innovative testing methods such as urine, saliva, hair, and blood analyses,",
    "url": "https://finance.yahoo.com/news/us-drug-abuse-testing-market-130100012.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "e0170ab8-d969-35fd-9ec9-151579167cfa",
      "content": {
        "id": "e0170ab8-d969-35fd-9ec9-151579167cfa",
        "contentType": "STORY",
        "title": "US Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic",
        "description": "",
        "summary": "The United States Drug Abuse Testing Market is projected to grow significantly, reaching US$ 3.71 billion by 2033, up from US$ 2 billion in 2024, reflecting a CAGR of 7.11% from 2025 to 2033. This growth is driven by increasing substance misuse, stringent workplace regulations, technological advancements, government support, and rising public awareness. The sector is essential in tackling drug-related challenges through innovative testing methods such as urine, saliva, hair, and blood analyses,",
        "pubDate": "2025-09-15T13:01:00Z",
        "displayTime": "2025-09-15T13:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/2cf3bfc830cf03daff1788b6a3414baf",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "U.S. Drug Abuse Testing Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uvHM9PAcmprNaoQL_DHZDQ--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2cf3bfc830cf03daff1788b6a3414baf.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IbJNl92B4bSMVoi.RY0dCg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2cf3bfc830cf03daff1788b6a3414baf.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/us-drug-abuse-testing-market-130100012.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/us-drug-abuse-testing-market-130100012.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            },
            {
              "symbol": "DGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]